Drug Trial Radar · NCT01203345
Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection
Last checked: Nov 20, 2026Latest source record: Mar 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,416
Actual
Start
Jan 1988
Primary completion
Mar 1991
Study completion Mar 1991
Sponsor
- Lead sponsor
- NICHD Neonatal Research NetworkResearch network
- Sponsor type
- Research network
- First posted
- Sep 16, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, up to 72 hours
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A controlled clinical trial was conducted at eight participating centers between January 1, 1988, and March 31, 1991. Patients were randomly assigned to an intravenous immune globulin group or a control group. There were two phases to the study (see below). During phase 1 the control infants received infusions of placebo. During phase 2 the control infants received no infusion therapy.
Conditions
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Sepsis
Interventions
IVIGDrug
The infants received their first dose of study drug within 24 hours of randomization.
PlaceboDrug
An equal volume of 5 percent albumin solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of nosocomial infectionTime frame: 120 days of life
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
George Washington University
Washington D.C., District of Columbia
University of Miami
Miami, Florida
Wayne State University
Detroit, Michigan
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio
University of Tennessee
Memphis, Tennessee
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
University of Vermont
Burlington, Vermont
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.